20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants

Sponsor
Pfizer (Industry)
Overall Status
Active, not recruiting
CT.gov ID
NCT04379713
Collaborator
(none)
1,513
97
2
27.3
15.6
0.6

Study Details

Study Description

Brief Summary

This study is designed to evaluate the safety and tolerability of 20vPnC in healthy infants.

Condition or Disease Intervention/Treatment Phase
  • Biological: 20-valent pneumococcal conjugate vaccine
  • Biological: 13-valent pneumococcal conjugate vaccine
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
1513 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS
Actual Study Start Date :
May 21, 2020
Anticipated Primary Completion Date :
Aug 31, 2022
Anticipated Study Completion Date :
Aug 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: 20-valent pneumococcal conjugate vaccine

Pneumococcal conjugate vaccine

Biological: 20-valent pneumococcal conjugate vaccine
Pneumococcal conjugate vaccine

Active Comparator: 13-valent pneumococcal conjugate vaccine

Pneumococcal conjugate vaccine

Biological: 13-valent pneumococcal conjugate vaccine
Pneumococcal conjugate vaccine

Outcome Measures

Primary Outcome Measures

  1. Percentage of participants reporting prompted local reactions within 7 days after each dose in each group (redness, swelling, and pain at the injection site) [Day 7]

    Prompted local reactions after each dose in each group

  2. Percentage of participants reporting prompted systemic events within 7 days after each dose in each group (fever, decreased appetite, irritability, and drowsiness/increased sleep) [Day 7]

    Prompted systemic reactions after each dose in each group

  3. Percentage of participants reporting adverse events from Dose 1 through 1 month after Dose 3 in each group [1 month after Dose 3]

    Adverse events occurring from Dose 1 through 1 month after Dose 3 in each group

  4. Percentage of participants reporting adverse events from Dose 4 through 1 month after Dose 4 in each group [1 month after Dose 4]

    Adverse events occurring from Dose 4 through 1 month after Dose 4 in each group

  5. Percentage of participants reporting SAEs up to 6 months after Dose 4 in each group [6 months after Dose 4]

    SAEs occurring up to 6 months after Dose 4 in each group

  6. Percentage of participants reporting Newly Diagnosed Chronic Medical Conditions (NDCMCs) up to 6 months after Dose 4 in each group [6 months after Dose 4]

    NDCMCs occurring up to 6 months after Dose 4 in each group

Eligibility Criteria

Criteria

Ages Eligible for Study:
42 Days to 98 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male or female infants born at ≥34 weeks of gestation and who are 2 months of age (≥42 to ≤98 days) at the time of consent (the day of birth is considered day of life 1).

  • Healthy infants determined by clinical assessment, including medical history and clinical judgment, to be eligible for the study.

Exclusion Criteria:
  • Previous vaccination with any licensed or investigational pneumococcal vaccine, or planned receipt through study participation.

  • Major known congenital malformation or serious chronic disorder.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Eclipse Clinical Research Tucson Arizona United States 85745
2 Good Samaritan Family Health Team Fullerton California United States 92831
3 FocilMed Oxnard California United States 93030
4 Superior Research, LLC Sacramento California United States 95831
5 Carey Chronis, MD Ventura California United States 93003
6 Fomat - Robert Nudelman MD Westlake Village California United States 91361
7 Ebert Family Clinic Frisco Colorado United States 80443
8 Advanced Research for Health Improvement, LLC Fort Myers Florida United States 33907
9 Pensacola Pediatrics Gulf Breeze Florida United States 32563
10 Y&L Advance Health Care Inc, d/b/a Elite Miami Florida United States 33144
11 Advanced Research for Health Improvement, LLC Naples Florida United States 34102
12 Citadelle Clinical Research North Miami Beach Florida United States 33162
13 Avanza Medical Research Center Pensacola Florida United States 32503
14 Pensacola Pediatrics Pensacola Florida United States 32504
15 KIDZ Medical Services Pediatric Pulmonary Center South Miami Florida United States 33143
16 Teena Hughes/PAS Research Tampa Florida United States 33613
17 Idaho Falls Pediatrics Ammon Idaho United States 83406
18 Elite Clinical Trials LLLP Blackfoot Idaho United States 83221
19 Idaho Falls Pediatrics Idaho Falls Idaho United States 83402
20 Clinical Research Prime Idaho Falls Idaho United States 83404
21 The Pediatric Center Idaho Falls Idaho United States 83404
22 Cotton O'Neil Clinical Research Center, Pediatrics Topeka Kansas United States 66604
23 All Children Pediatrics Louisville Kentucky United States 40243
24 Boston Medical Center Boston Massachusetts United States 02118
25 MedClinical Research Partners, LLC East Orange New Jersey United States 07018
26 Advantage Clinical Trials Bronx New York United States 10468
27 Pediatric Partners, PA Raleigh North Carolina United States 27609
28 PMG Research Inc., d/b/a PMG Research of Piedmont HealthCare Statesville North Carolina United States 28625
29 Ford Simpson Lively and Rice Pedtrics, PA (Wake Health Network) Winston-Salem North Carolina United States 27103
30 PMG Research of Winston-Salem Winston-Salem North Carolina United States 27103
31 Omega Medical Research Warwick Rhode Island United States 02886
32 Coastal Pediatric Research Summerville South Carolina United States 29486
33 The Jackson Clinic, PA Jackson Tennessee United States 38305
34 Advent Health Family Medicine Rural Health Clinics, Inc. Lampasas Texas United States 76550
35 FMC Science Lampasas Texas United States 76550
36 Maximos Ob/Gyn League City Texas United States 77573
37 Rio Grande Valley Clinical Research Institute Pharr Texas United States 78577
38 Tanner Clinic Layton Utah United States 84041
39 Wasatch Pediatrics - St. Marks Office Salt Lake City Utah United States 84124
40 CopperView Medical Center South Jordan Utah United States 84095
41 PI-Coor Clinical Research LLC Burke Virginia United States 22015
42 Clinica Mayo UMCB S.R.L. San Miguel de Tucuman Tucuman Argentina 4000
43 Hospital del Nino Jesus San Miguel de Tucuman Tucuman Argentina 4000
44 Centro Medico Dra. De Salvo Buenos Aires Argentina C1426ABP
45 Aggarwal and Associates Limited Brampton Ontario Canada L6T 0G1
46 Dawson Clinical Research Inc. Guelph Ontario Canada N1H 1B1
47 Milestone Research , Inc London Ontario Canada N5W 6A2
48 Bluewater Clinical Research Group Inc. Sarnia Ontario Canada N7T 4X3
49 Dr. Hartley Garfield Medicine Professional Corporation Toronto Ontario Canada M5G 1N8
50 Centre hospitalier universitaire (CHU) Sainte-Justine Montreal Quebec Canada H3T 1C5
51 McGill University Health Centre, Vaccine Study Centre Pierrefonds Quebec Canada H9H 4Y6
52 CHU de Quebec-Universite Laval Québec City Quebec Canada G1E 7G9
53 CESFAM Colina Colina, Santiago Región Metropolitana Chile 9350079
54 CESFAM Esmeralda Colina, Santiago Región Metropolitana Chile
55 Biocinetic Santiago Región Metropolitana Chile 8331143
56 Grupo Estudios Clínicos Infectología Respiratoria Santiago Región Metropolitana Chile 8380453
57 Hospital Padre Hurtado Santiago Región Metropolitana Chile 8880465
58 Ordinace praktickeho lekare pro deti a dorost Hradec Kralove Czechia 50004
59 Ordinace praktickeho lekare pro deti a dorost Jindrichuv Hradec II Czechia 377 01
60 Detska ambulance Petriny spol. s r.o. Veleslavin Czechia 162 00
61 MeVac, Meilahti Vaccine Research Center Helsinki Finland 00290
62 SIBAmed GmbH & Co.KG Leipzig Saxony Germany 04103
63 Kinderarztpraxis Bramsche Bramsche Germany 49565
64 Arztpraxis Dr. med. Dr. rer. nat. Helmut Pabel Herford Germany 32049
65 Praxis fuer Kinderpneumologie und Allergologie Mannheim Mannheim Germany 68161
66 Kinderarztpraxis Ralph Köllges, Jacek Mossakowski, Dr. med. Martina Meyer-Krott Mönchengladbach Germany 41236
67 Praxis Dr. med. Joachim Weimer Reinfeld Germany 23858
68 University General Hospital of Heraklion Heraklion Crete Greece 71110
69 General University Hospital of Larissa Larissa Thessaly Greece 41110
70 "Aghia Sophia" Children's Hospital Athens Greece 11527
71 P. and A. Kyriakou Children's Hospital Athens Greece 11527
72 University General Hospital "ATTIKON" Athens Greece 12462
73 "Ippokratio" General Hospital of Thessaloniki Thessaloniki Greece 54642
74 Papp és Tsa Eü és Szolg Bt Szigetvar Baranya Hungary 7900
75 Dr Pölöskey Péter Egyéni Cég Házi Gyermekorvosi Szolgálat Szombathely Szombathely VAS Megye Hungary 9700
76 Gyerkőc Med Bt. Házi Gyermekorvosi Rendelő Budapest Hungary 1042
77 Futurenest Kft. Pestszentimrei Gyermekrendelő Budapest Hungary 1188
78 Gyorine dr Bari Eszter E. V. 1. sz. Gyermek Haziorvosi Praxis Csongrad Hungary 6640
79 Futurenest Kft. 16. házi gyermekorvosi rendelő Debrecen Hungary 4025
80 Mimiped Bt Gyor Hungary 9024
81 Futurenest Kft Miskolc Hungary 3527
82 Bettimedical BT Szazhalombatta Hungary 2440
83 Ponce Medical School Foundation Inc./ CAIMED Center Ponce Puerto Rico 00176
84 CHUS - Hospital Clinico Universitario Santiago de Compostela A Coruna Spain 15706
85 Hospital Universitari General de Catalunya Sant Cugat del Valles Barcelona Spain 08195
86 Centro de Salud de Burriana II Burriana Castellon Spain 12530
87 Hospital Universitario de Burgos Burgos Castilla Y LEON Spain 09006
88 Hospital Universitario HM Monteprincipe Boadilla del Monte Madrid Spain 28660
89 Centro de Salud L'Eliana L'Eliana Valencia Spain 46183
90 Centro de Salud de Paiporta Paiporta Valencia Spain 46200
91 Clinica Corachan Barcelona Spain 08017
92 Hospital Universitario 12 de Octubre Madrid Spain 28041
93 Hospital Universitario La Paz Madrid Spain 28046
94 Grupo Pediatrico Uncibay Malaga Spain 29015
95 Centro de Salud de Malvarrosa Valencia Spain 46011
96 FISABIO Valencia Spain 46020
97 Centro de Salud la Serreria II Valencia Spain 46022

Sponsors and Collaborators

  • Pfizer

Investigators

  • Study Director: Pfizer CT.gov Call Center, Pfizer

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Pfizer
ClinicalTrials.gov Identifier:
NCT04379713
Other Study ID Numbers:
  • B7471013
  • 2019-003307-35
First Posted:
May 7, 2020
Last Update Posted:
Aug 9, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 9, 2022